Case Studies: How UMC Contributed to Drug Safety Alerts Globally

Case Studies: How UMC Contributed to Drug Safety Alerts Globally Case Studies: How UMC Contributed to Drug Safety Alerts Globally In the fast-paced domain of pharmaceutical safety and regulatory compliance, understanding the role of the Uppsala Monitoring Centre (UMC) is crucial. This comprehensive guide aims to explore the practical steps that regulatory affairs professionals can take to utilize UMC resources effectively, particularly in drug safety alerts. It will cover the procedural framework as outlined by the UMC, emphasizing regulatory compliance consulting for US-focused organizations. This guide offers specifics on utilizing VigiBase, VigiFlow, signal detection methods, and MedDRA coding appropriate for…

Continue Reading... Case Studies: How UMC Contributed to Drug Safety Alerts Globally

VigiBase Signal Detection for US PV Teams: Practical Workflow and Metrics in 2025

VigiBase Signal Detection for US PV Teams: Practical Workflow and Metrics in 2023 VigiBase Signal Detection for US PV Teams: Practical Workflow and Metrics in 2023 Pharmacovigilance outsourcing has become a critical element in the landscape of drug safety and efficacy monitoring. One essential tool for pharmacovigilance teams is VigiBase, the World Health Organization’s global database of reported adverse drug reactions. This article provides a comprehensive step-by-step guide specifically for US pharmacovigilance (PV) teams on how to efficiently implement signal detection within the VigiBase system. Through this tutorial, readers will gain insights into workflows, performance metrics, and compliance with relevant…

Continue Reading... VigiBase Signal Detection for US PV Teams: Practical Workflow and Metrics in 2025

VigiFlow Data Submission Quality: US Vendor Oversight Checklist for 2025

VigiFlow Data Submission Quality: US Vendor Oversight Checklist for 2023 VigiFlow Data Submission Quality: US Vendor Oversight Checklist for 2023 In the evolving landscape of pharmacovigilance, ensuring the quality of data submitted to regulatory authorities is of utmost importance. Vendors and organizations must adhere to stringent guidelines to avoid compliance issues and ensure the safety of medicinal products. This article aims to provide a comprehensive, step-by-step tutorial guide for preparing for data submissions using VigiFlow, particularly focused on quality control and vendor oversight processes, emphasizing the FDA and UMC guidelines for 2023. Step 1: Understanding the VigiFlow System and Requirements…

Continue Reading... VigiFlow Data Submission Quality: US Vendor Oversight Checklist for 2025

MedDRA Coding Governance: US Audit-Ready Controls for Global Safety Reporting

MedDRA Coding Governance: US Audit-Ready Controls for Global Safety Reporting MedDRA Coding Governance: US Audit-Ready Controls for Global Safety Reporting Ensuring compliance with MedDRA coding governance standards is essential for pharmaceutical and biotechnology companies engaged in global safety reporting. As regulatory oversight increases, so does the need for robust, audit-ready controls that align with both Good Manufacturing Practices (GMP) and international regulatory expectations, including those set forth by the FDA and the Uppsala Monitoring Centre (UMC). This article serves as a comprehensive step-by-step guide to establishing and maintaining effective MedDRA coding governance in the United States, focusing on the implementation…

Continue Reading... MedDRA Coding Governance: US Audit-Ready Controls for Global Safety Reporting

UMC Signal Sharing: How US Companies Use WHO PIDM Outputs for Risk Management

UMC Signal Sharing: How US Companies Use WHO PIDM Outputs for Risk Management UMC Signal Sharing: How US Companies Use WHO PIDM Outputs for Risk Management Step 1: Understanding the Framework of Pharmacovigilance Outsourcing In the realm of pharmacovigilance, the outsourcing of responsibilities has become a common practice to streamline operations while ensuring compliance with regulatory standards. Pharmacovigilance outsourcing involves delegating the monitoring of drug safety and the reporting of adverse events to external service providers. This method is advantageous for companies that lack the requisite infrastructure or expertise. However, it entails rigorous adherence to guidelines set forth by regulatory…

Continue Reading... UMC Signal Sharing: How US Companies Use WHO PIDM Outputs for Risk Management

PV KPI Dashboard: UMC-Aligned Indicators for US Pharmacovigilance QMS in 2025

PV KPI Dashboard: UMC-Aligned Indicators for US Pharmacovigilance QMS in 2023 PV KPI Dashboard: UMC-Aligned Indicators for US Pharmacovigilance QMS in 2023 In the ever-evolving landscape of pharmacovigilance, aligning with global standards is crucial for maintaining compliance and ensuring drug safety. This step-by-step tutorial focuses on implementing a Pharmacovigilance (PV) Key Performance Indicator (KPI) Dashboard that aligns with the Uppsala Monitoring Centre (UMC) indicators specifically designed for US regulatory submissions. The aim is to offer practical guidance, checklists, and templates to streamline your compliance efforts. Each section will provide concrete actions, addressing essential requirements under FDA regulations and best practices….

Continue Reading... PV KPI Dashboard: UMC-Aligned Indicators for US Pharmacovigilance QMS in 2025